로딩 중…
지수 로딩 중…
Oculis Holding AG
OCS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CH
CH$11.22-0.71%
2026-06-18
Price Chart
Oculis Holding AG-42.40%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $678M |
| Revenue | $607701.00 |
| Net Income | $-115M |
| Total Assets | $307M |
| Net Assets | $247M |
| Value | |
| P/B | 2.74x |
| FCF Yield | -11.12% |
| Profitability | |
| ROE | -46.35% |
| ROA | -37.35% |
| Op. Margin | -16740.94% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 24.08% |
| Total Debt | $3M |
| FCF | $-75M |
| Cash | $81M |
| Current Ratio | 5.18x |
| Performance | |
| 1Y Return | -42.40% |
| 1M Return | -59.87% |
| From 52W High | -67.46% |
| 1Y MDD | -67.20% |
| Trading | |
| Volume | 750,161 shares |
| Trading Value | $8M |
| Per Share | |
| EPS | $-1.98 |
| BPS | $3.94 |